CAMTA1 immunohistochemistry: understanding the finding

It is a test performed on tissue, not a blood test or scan. The pathologist looks for staining in the nuclei of the abnormal cells and interprets that pattern within the full biopsy assessment.

Strong nuclear staining in the cells of a suspected vascular tumour can add support for epithelioid hemangioendothelioma. This tumour is commonly associated with a genetic rearrangement that brings together WWTR1 and CAMTA1, which leads to abnormal CAMTA1 expression detectable by the stain.

A pathologist does not interpret CAMTA1 alone. The diagnosis also depends on the architecture and features of the cells, evidence that the tumour has vascular differentiation, the body site, and results from other stains. Unexpected or borderline staining may require molecular testing that looks directly for the relevant rearrangement.

Read the CAMTA1 result alongside the final diagnosis and comment section of the pathology report. If the wording says the findings are supportive rather than definitive, ask what alternatives remain and whether molecular confirmation is planned.

Once the diagnosis is settled, the clinical team may use imaging and details such as tumour location, extent, symptoms, and whether it can be removed to plan care. Complex vascular tumours often benefit from review by a pathologist and clinical team familiar with sarcomas.

CAMTA1 staining does not determine urgency by itself. Report new or worsening symptoms related to the affected body area, especially increasing pain, swelling, weakness, breathing difficulty, or reduced function. Seek urgent medical help for severe breathing difficulty, fainting, uncontrolled bleeding, or a sudden major change in symptoms.

Following a biopsy, contact the procedure team about fever, spreading redness, discharge, bleeding that continues despite firm pressure, or pain that keeps intensifying.

Consider asking whether staining was clearly nuclear, which vascular markers supported the interpretation, and whether genetic testing is needed. Other practical questions include whether the pathology needs specialist review, what imaging is required, and which specialists will help plan management.